Stericycle (NASDAQ:SRCL) Earns Hold Rating from Analysts at StockNews.com

StockNews.com started coverage on shares of Stericycle (NASDAQ:SRCL) in a research note issued on Friday. The firm set a “hold” rating on the business services provider’s stock.

Stericycle Trading Down 0.2 %

NASDAQ:SRCL opened at $60.81 on Friday. Stericycle has a 52 week low of $37.78 and a 52 week high of $61.77. The firm has a 50 day moving average of $60.11 and a 200 day moving average of $55.73. The company has a quick ratio of 1.13, a current ratio of 1.13 and a debt-to-equity ratio of 0.55. The stock has a market capitalization of $5.65 billion, a price-to-earnings ratio of -276.41, a PEG ratio of 3.32 and a beta of 1.11.

Stericycle (NASDAQ:SRCL) last posted its quarterly earnings results on Thursday, July 25th. The business services provider reported $0.61 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.57 by $0.04. The business had revenue of $661.60 million during the quarter, compared to analysts’ expectations of $672.07 million. Stericycle had a net margin of 1.37% and a return on equity of 7.94%. As a group, sell-side analysts anticipate that Stericycle will post 2.29 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Stericycle

A number of institutional investors have recently modified their holdings of SRCL. Clearstead Trust LLC purchased a new position in shares of Stericycle during the 1st quarter valued at about $25,000. GAMMA Investing LLC raised its stake in shares of Stericycle by 170.9% during the 1st quarter. GAMMA Investing LLC now owns 818 shares of the business services provider’s stock valued at $43,000 after buying an additional 516 shares during the last quarter. Headlands Technologies LLC purchased a new position in shares of Stericycle during the 1st quarter valued at about $44,000. International Assets Investment Management LLC purchased a new position in shares of Stericycle during the 2nd quarter valued at about $45,000. Finally, Quest Partners LLC raised its stake in shares of Stericycle by 4,172.7% during the 2nd quarter. Quest Partners LLC now owns 940 shares of the business services provider’s stock valued at $55,000 after buying an additional 918 shares during the last quarter. Hedge funds and other institutional investors own 98.82% of the company’s stock.

Stericycle Company Profile

Stericycle, Inc, together with its subsidiaries, provides regulated waste and compliance services in the United States, Europe, and internationally. The company offers regulated waste and compliance services, including regulated medical waste, sharps waste management and disposal, pharmaceutical waste management and disposal, chemotherapy waste and disposal, controlled substance waste disposal, healthcare hazardous waste, and integrated waste stream solutions; specialty services, such as MedDrop medication collection kiosks, safe community solutions, SafeDrop sharps mailback solutions, and airport and maritime waste services; medical supply store services, that includes sharps and disposable biohazardous waste containers, infection control supplies, and seal&send medication mail back; and compliance solutions including Steri-Safe compliance solutions.